Cybercriminals are increasingly targeting healthcare organizations due to their vast stores of sensitive data, including patients' financial details, medical records, and personal information. This data commands high prices on the dark web.
The Am Law 100 ranks the largest 100 law firms in the United States. It offers dynamic tools to explore and compare data on firms, companies, lawyers, and industry trends. Users receive real-time alerts on new litigation at state and federal levels, unlimited complaint access, expert case summaries, and AI-enhanced trend detection.
Pfizer has sought a temporary restraining order to prevent Metsera from breaching its contract with Pfizer by making a deal with Novo Nordisk. The court noted:
"A reasonable juror could find that the defendants’ 'blaming supply,' making uncompetitively high bids and falsely citing production costs for increased prices were aimed at concealing their alleged conspiracy."
Pfizer accuses Novo Nordisk of trying to "catch and kill" Metsera, a company Pfizer was acquiring, to block competition against Novo Nordisk’s obesity treatments, Ozempic and Wegovy.
Author’s summary: Cyberattacks on healthcare data and intense corporate legal battles underline the high stakes in protecting sensitive patient information and market competition in the pharmaceutical industry.